| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.23 | 8e-05 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.15 | 0.008 |